| Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study T Marjot, AM Moon, JA Cook, S Abd-Elsalam, C Aloman, MJ Armstrong, ... Journal of hepatology 74 (3), 567-577, 2021 | 541 | 2021 |
| Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review A Eshraghian, AH Jahromi World journal of gastroenterology: WJG 20 (25), 8102, 2014 | 205 | 2014 |
| Epidemiology of Helicobacter pylori infection among the healthy population in Iran and countries of the Eastern Mediterranean Region: a systematic review of prevalence and risk … A Eshraghian World journal of gastroenterology: WJG 20 (46), 17618, 2014 | 185 | 2014 |
| Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors A Eshraghian, MH Dabbaghmanesh, H Eshraghian, MR Fattahi, ... Archives of Iranian medicine 16 (10), 0-0, 2013 | 154 | 2013 |
| Helicobacter pylori Infection as a Risk Factor for Insulin Resistance A Eshraghian, SA Hashemi, AH Jahromi, H Eshraghian, SM Masoompour, ... Digestive diseases and sciences 54, 1966-1970, 2009 | 99 | 2009 |
| Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial MH Dabbaghmanesh, F Danafar, A Eshraghian, GR Omrani Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12 (4), 513-517, 2018 | 64 | 2018 |
| Current and emerging pharmacological therapy for non-alcoholic fatty liver disease A Eshraghian World journal of gastroenterology 23 (42), 7495, 2017 | 63 | 2017 |
| Primary hypothyroidism presenting with Torsades de pointes type tachycardia: a case report M Shojaie, A Eshraghian Cases journal 1, 1-4, 2008 | 61 | 2008 |
| Comparison of chromoendoscopy and conventional endoscopy in the detection of premalignant gastric lesions SA Taghavi, ME Membari, A Eshraghian, SM Dehghani, L Hamidpour, ... Canadian Journal of Gastroenterology and Hepatology 23 (2), 105-108, 2009 | 56 | 2009 |
| European guideline on obesity care in patients with gastrointestinal and liver diseases–Joint ESPEN/UEG guideline SC Bischoff, R Barazzoni, L Busetto, M Campmans-Kuijpers, V Cardinale, ... Clinical Nutrition 41 (10), 2364-2405, 2022 | 53 | 2022 |
| Systematic review: endocrine abnormalities in patients with liver cirrhosis A Eshraghian, SA Taghavi Archives of Iranian Medicine 17 (10), 0-0, 2014 | 51 | 2014 |
| Interstitial cells of Cajal: a novel hypothesis for the pathophysiology of irritable bowel syndrome A Eshraghian, H Eshraghian Canadian Journal of Gastroenterology and Hepatology 25 (5), 277-279, 2011 | 51 | 2011 |
| Fibrinogen as a risk factor for premature myocardial infarction in Iranian patients: a case control study M Shojaie, M Pourahmad, A Eshraghian, HR Izadi, F Naghshvar Vascular health and risk management, 673-676, 2009 | 50 | 2009 |
| The case for simplifying and using absolute targets for viral hepatitis elimination goals Polaris Observatory Collaborators, H Razavi, S Blach, D Razavi-Shearer, ... Journal of viral hepatitis 28 (1), 12-19, 2021 | 49 | 2021 |
| Anti-Inflammatory, gastrointestinal and hepatoprotective effects of Ocimum sanctum Linn: an ancient remedy with new application A Eshraghian Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets …, 2013 | 47 | 2013 |
| Colchicine is effective for short-term treatment of slow transit constipation: a double-blind placebo-controlled clinical trial SA Taghavi, S Shabani, A Mehramiri, A Eshraghian, SMH Kazemi, ... International journal of colorectal disease 25, 389-394, 2010 | 45 | 2010 |
| Seroprevalence study of hepatitis A virus in Fars province, southern Iran SA Taghavi, MKH Asl, M Talebzadeh, A Eshraghian Hepatitis monthly 11 (4), 285, 2011 | 44 | 2011 |
| Hyperlipidemia in Iranian liver transplant recipients: prevalence and risk factors SM Dehghani, SAR Taghavi, A Eshraghian, S Gholami, MH Imanieh, ... Journal of gastroenterology 42, 769-774, 2007 | 42 | 2007 |
| Safety of topical methimazole for the treatment of melasma: Transdermal absorption, the effect on thyroid function and cutaneous adverse effects B Kasraee, GH Safaee Ardekani, A Parhizgar, F Handjani, GR Omrani, ... Skin pharmacology and physiology 21 (6), 300-305, 2008 | 40 | 2008 |
| Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis A Eshraghian, S Nikeghbalian, B Geramizadeh, SA Malek-Hosseini United European Gastroenterology Journal 6 (1), 97-103, 2018 | 39 | 2018 |
